GUANGDONG KANG.CO.LTD YC1
Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People's Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers reproduc… Read more
GUANGDONG KANG.CO.LTD YC1 (E9Q) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, GUANGDONG KANG.CO.LTD YC1 (E9Q) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
GUANGDONG KANG.CO.LTD YC1 - Net Assets Trend (None–None)
This chart illustrates how GUANGDONG KANG.CO.LTD YC1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GUANGDONG KANG.CO.LTD YC1 (None–None)
The table below shows the annual net assets of GUANGDONG KANG.CO.LTD YC1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to GUANGDONG KANG.CO.LTD YC1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
GUANGDONG KANG.CO.LTD YC1 Competitors by Market Cap
The table below lists competitors of GUANGDONG KANG.CO.LTD YC1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NKGen Biotech, Inc. Common Stock
PINK:NKGN
|
$7.84 Million |
|
CT AUTOMOTIVE GROUP -005
F:X7X
|
$7.84 Million |
|
Boldt S.A
BA:BOLT
|
$7.84 Million |
|
EPB Group Berhad
KLSE:0317
|
$7.84 Million |
|
Odonate Therapeutics
PINK:ODTC
|
$7.83 Million |
|
Keystone Reit Ltd
TA:KSTN
|
$7.83 Million |
|
Nico Resources Ltd
AU:NC1
|
$7.83 Million |
|
Energy Plug Technologies Corp
OTCQB:PLGGF
|
$7.83 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GUANGDONG KANG.CO.LTD YC1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares GUANGDONG KANG.CO.LTD YC1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently GUANGDONG KANG.CO.LTD YC1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares GUANGDONG KANG.CO.LTD YC1's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,542,527,848
- Average return on equity (ROE) among peers: 7.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GUANGDONG KANG.CO.LTD YC1 (E9Q) | €- | N/A | N/A | $7.83 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |